Major adverse cardiovascular events and hyperuricemia as an effect-modifying factor in kidney transplant recipients

Table 3 Association between major adverse cardiovascular events and independent variables–main model

Variable	Odds ratio	95%CI	P value	Wald statistics
Age (years)	1.05	1.03–1.08	< 0.01	21.13
Receiving hyperuricemia treatment	4.29	2.44–7.57	< 0.01	25.42
Having previous cardiovascular events	70.6	24.9–200.1	< 0.01	64.03
Having left ventricular hypertrophy	12.6	2.74–58.3	< 0.01	10.56
Having anemia	5.32	2.89–9.80	< 0.01	28.82

Effect modification by a level of uric acid.